US5569469A
(en)
*
|
1984-10-16 |
1996-10-29 |
Vectorpharma International, S.P.A. |
Poorly soluble medicaments supported on polymer substances in a form suitable for increasing their dissolving rate
|
IT1241088B
(it)
*
|
1990-03-27 |
1993-12-29 |
Chiesi Farma Spa |
Procedimento per la preparazione di complessi piroxicam/ciclodestrina,prodotti ottenuti e loro composizioni farmaceutiche
|
HU210921B
(en)
*
|
1990-03-28 |
1995-09-28 |
Chinoin Gyogyszer Es Vegyeszet |
Process for preparing inclusion complexes of n-ethoxycarbonyl-3-morpholino-sydnonimine formed with cyclodextrines and pharmaceutical compositions containing them
|
IT1246188B
(it)
*
|
1990-07-27 |
1994-11-16 |
Resa Farma |
Procedimento per la preparazione di composizioni farmaceutiche aventi aumentata velocita' di dissoluzione della sostanza attiva e composizioni ottenute.
|
IT1243745B
(it)
*
|
1990-10-17 |
1994-06-21 |
Vectorpharma Int |
Composizioni terapeutiche transdermali contenenti farmaco e/o agente promotore dell'assorbimento cutaneo supportato su particelle microporose e microsfere polimeriche e loro preparazione.
|
US5399363A
(en)
*
|
1991-01-25 |
1995-03-21 |
Eastman Kodak Company |
Surface modified anticancer nanoparticles
|
US5552160A
(en)
*
|
1991-01-25 |
1996-09-03 |
Nanosystems L.L.C. |
Surface modified NSAID nanoparticles
|
EP0519428B1
(en)
*
|
1991-06-21 |
2000-09-20 |
Takeda Chemical Industries, Ltd. |
Cyclodextrin compositions with fumagillol derivates
|
DE69309056T2
(de)
*
|
1992-06-10 |
1997-09-18 |
Nanosystems Llc |
Oberflaechenmodifizierte nsaid nanopartikeln
|
IT1255462B
(it)
*
|
1992-07-28 |
1995-11-02 |
Grazia Maffione |
Metodo di preparazione di composti di inclusione di nimesulide con ciclodestrine
|
AU660852B2
(en)
*
|
1992-11-25 |
1995-07-06 |
Elan Pharma International Limited |
Method of grinding pharmaceutical substances
|
HU213200B
(en)
|
1993-05-12 |
1997-03-28 |
Chinoin Gyogyszer Es Vegyeszet |
The cyclodextrin or cyclodextrin derivative cluster complexes of taxol, taxotere, or taxus, pharmaceutical preparations containing them and process for their production
|
GB9316580D0
(en)
*
|
1993-08-10 |
1993-09-29 |
Smithkline Beecham Plc |
Pharmaceutical composition
|
TW384224B
(en)
*
|
1994-05-25 |
2000-03-11 |
Nano Sys Llc |
Method of preparing submicron particles of a therapeutic or diagnostic agent
|
US5684121A
(en)
*
|
1994-12-06 |
1997-11-04 |
Isp Investments Inc. |
N-vinyl lactam polymer containing tablets of low friability and high rate of dissolution
|
US5547948A
(en)
*
|
1995-01-17 |
1996-08-20 |
American Home Products Corporation |
Controlled release of steroids from sugar coatings
|
US5759577A
(en)
*
|
1995-01-17 |
1998-06-02 |
American Home Products Corporation |
Controlled release of steroids from sugar coatings
|
US5518738A
(en)
*
|
1995-02-09 |
1996-05-21 |
Nanosystem L.L.C. |
Nanoparticulate nsaid compositions
|
US5612053A
(en)
|
1995-04-07 |
1997-03-18 |
Edward Mendell Co., Inc. |
Controlled release insufflation carrier for medicaments
|
US6348469B1
(en)
|
1995-04-14 |
2002-02-19 |
Pharma Pass Llc |
Solid compositions containing glipizide and polyethylene oxide
|
DK0822808T3
(da)
*
|
1995-04-20 |
2000-10-09 |
Eurand Int |
Kompositmateriale med natriumstivelsesglycolat som bærermateriale og produkter deraf
|
US20050267302A1
(en)
*
|
1995-12-11 |
2005-12-01 |
G.D. Searle & Co. |
Eplerenone crystalline form exhibiting enhanced dissolution rate
|
US5686133A
(en)
*
|
1996-01-31 |
1997-11-11 |
Port Systems, L.L.C. |
Water soluble pharmaceutical coating and method for producing coated pharmaceuticals
|
HUP9600758A2
(en)
*
|
1996-03-27 |
1998-03-02 |
Cyclolab Ciklodextrin Kutato F |
Diclofenac composition of diminished gastrointestinal irritation and enhanced biological resorption
|
US6048547A
(en)
*
|
1996-04-15 |
2000-04-11 |
Seth; Pawan |
Process for manufacturing solid compositions containing polyethylene oxide and an active ingredient
|
WO1997039761A1
(en)
|
1996-04-19 |
1997-10-30 |
Alpha Therapeutic Corporation |
A process for viral inactivation of lyophilized blood proteins
|
FR2757397B1
(fr)
*
|
1996-12-23 |
1999-03-05 |
Mazal Pharma |
Composition pharmaceutique a base de rheine ou de diacerheine a biodisponibilite amelioree
|
US20050004049A1
(en)
*
|
1997-03-11 |
2005-01-06 |
Elan Pharma International Limited |
Novel griseofulvin compositions
|
US6797289B2
(en)
*
|
1998-02-13 |
2004-09-28 |
Nutramax Laboratories, Inc. |
Use of anabolic agents, anti-catabolic agents, antioxidant agents, and analgesics for protection, treatment and repair of connective tissues in humans and animals
|
US20070141181A1
(en)
*
|
1998-02-13 |
2007-06-21 |
Nutramax Laboratories, Inc. |
Use of anabolic agents, anti-catabolic agents, antioxidant agents, and analgesics for protection, treatment and repair of connective tissues in humans and animals
|
US6451771B1
(en)
|
1999-02-12 |
2002-09-17 |
Nutramax Laboratories, Inc. |
Use of anabolic agents anti-catabolic agents and antioxidant agents for protection treatment and repair of connective tissues in humans and animals
|
US6086242A
(en)
*
|
1998-02-27 |
2000-07-11 |
University Of Utah |
Dual drive planetary mill
|
US6197347B1
(en)
|
1998-06-29 |
2001-03-06 |
Andrx Pharmaceuticals, Inc. |
Oral dosage for the controlled release of analgesic
|
US6524620B2
(en)
|
1998-07-20 |
2003-02-25 |
Andrx Pharmaceuticals, Inc. |
Diltiazem controlled release formulation and method of manufacture
|
FR2786100B1
(fr)
*
|
1998-11-24 |
2002-03-01 |
Aventis Laboratoire |
Nouvelle application therapeutique de la nicergoline
|
US6555139B2
(en)
|
1999-06-28 |
2003-04-29 |
Wockhardt Europe Limited |
Preparation of micron-size pharmaceutical particles by microfluidization
|
US6264981B1
(en)
|
1999-10-27 |
2001-07-24 |
Anesta Corporation |
Oral transmucosal drug dosage using solid solution
|
UA74539C2
(en)
|
1999-12-08 |
2006-01-16 |
Pharmacia Corp |
Crystalline polymorphous forms of celecoxib (variants), a method for the preparation thereof (variants), a pharmaceutical composition (variants)
|
CA2362845A1
(en)
*
|
1999-12-08 |
2001-06-14 |
Pharmacia Corporation |
Eplerenone crystalline form
|
ES2236007T3
(es)
*
|
1999-12-08 |
2005-07-16 |
Pharmacia Corporation |
Composiciones de inhibidor de ciclooxigenasa-2 ue tiene un efecto terapeutico rapido.
|
US20030083493A1
(en)
*
|
1999-12-08 |
2003-05-01 |
Barton Kathleen P. |
Eplerenone drug substance having high phase purity
|
US7108866B1
(en)
|
1999-12-10 |
2006-09-19 |
Biovall Laboratories International Srl |
Chronotherapeutic diltiazem formulations and the administration thereof
|
US20060153914A1
(en)
*
|
1999-12-10 |
2006-07-13 |
Biovail Laboratories International S.R.L. |
Chronotherapeutic diltiazem formulations and the administration thereof
|
AR035642A1
(es)
*
|
2000-05-26 |
2004-06-23 |
Pharmacia Corp |
Uso de una composicion de celecoxib para el alivio rapido del dolor
|
US20020146409A1
(en)
*
|
2001-01-30 |
2002-10-10 |
Herring Steven W. |
Methods for stabilizing lyophilized blood proteins
|
DK1406633T3
(da)
*
|
2001-06-18 |
2011-10-31 |
Noven Pharma |
Forbedret lægemiddeltilførsel i transdermale systemer
|
EP1269994A3
(en)
*
|
2001-06-22 |
2003-02-12 |
Pfizer Products Inc. |
Pharmaceutical compositions comprising drug and concentration-enhancing polymers
|
EA006777B1
(ru)
*
|
2001-06-22 |
2006-04-28 |
Пфайзер Продактс Инк. |
Фармацевтические композиции адсорбатов аморфного лекарственного средства
|
DE60223382T2
(de)
*
|
2001-06-29 |
2008-09-11 |
Eurand Pharmaceuticals Ltd., Bray |
Verfahren für die thermodynamische aktivierung von wasserlöslichen arzneimitteln, die in vernetzten polymeren geladen sind
|
US20030073609A1
(en)
|
2001-06-29 |
2003-04-17 |
Pinkerton Thomas C. |
Enhanced pharmacokinetic profile of intradermally delivered substances
|
JP2005529060A
(ja)
*
|
2001-09-25 |
2005-09-29 |
ファルマシア コーポレイション |
N−(2−ヒドロキシアセチル)−5−(4−ピペリヂル)−4−(4−ピリミヂニル)−3−(4−クロロフェニル)ピラゾールの固体形態
|
ES2305434T3
(es)
|
2002-02-01 |
2008-11-01 |
Pfizer Products Inc. |
Composiciones framaceuticas de dispersiones amorfas de farmacos y materiales que forman microfases lipofilas.
|
US20040105889A1
(en)
*
|
2002-12-03 |
2004-06-03 |
Elan Pharma International Limited |
Low viscosity liquid dosage forms
|
WO2003086354A1
(en)
*
|
2002-04-12 |
2003-10-23 |
Elan Pharma International Ltd. |
Nanoparticulate megestrol formulations
|
US9101540B2
(en)
|
2002-04-12 |
2015-08-11 |
Alkermes Pharma Ireland Limited |
Nanoparticulate megestrol formulations
|
US7101576B2
(en)
|
2002-04-12 |
2006-09-05 |
Elan Pharma International Limited |
Nanoparticulate megestrol formulations
|
US20100226989A1
(en)
*
|
2002-04-12 |
2010-09-09 |
Elan Pharma International, Limited |
Nanoparticulate megestrol formulations
|
ITMI20021074A1
(it)
*
|
2002-05-20 |
2003-11-20 |
Actimex S R L |
Composizione ternaria comprendente una sostanza attiva e processo di comacinazione per la sua preparazione
|
UY27939A1
(es)
|
2002-08-21 |
2004-03-31 |
Glaxo Group Ltd |
Compuestos
|
DE10259640A1
(de)
*
|
2002-12-18 |
2004-07-08 |
Hager & Werken Gmbh & Co Kg |
Einfärbemittel zur Sichtbarmachung von Plaque-Bildung auf Zähnen sowie Verfahren zur Herstellung eines solchen Einfärbemittels
|
US20040132771A1
(en)
*
|
2002-12-20 |
2004-07-08 |
Pfizer Inc |
Compositions of choleseteryl ester transfer protein inhibitors and HMG-CoA reductase inhibitors
|
US9498454B2
(en)
|
2003-02-24 |
2016-11-22 |
Pharmaceutical Productions Inc. |
Transmucosal drug delivery system
|
US9254294B2
(en)
|
2003-02-24 |
2016-02-09 |
Pharmaceutical Productions Inc. |
Transmucosal hormone delivery system
|
EP1599186B1
(en)
*
|
2003-02-24 |
2013-04-10 |
Pharmaceutical Productions Inc. |
Transmucosal drug delivery system
|
US10172810B2
(en)
|
2003-02-24 |
2019-01-08 |
Pharmaceutical Productions, Inc. |
Transmucosal ketamine delivery composition
|
US9358296B2
(en)
|
2003-02-24 |
2016-06-07 |
Pharmaceutical Productions Inc. |
Transmucosal drug delivery system
|
US20060141038A1
(en)
*
|
2003-06-27 |
2006-06-29 |
Bioprogress S. P. A. |
Composite product obtainable by cogrinding of a active principle with a copolymer n-vinyl-2 pyrrolidone/vinyl-acetate
|
DE602004000260T2
(de)
|
2003-07-22 |
2006-08-24 |
Arena Pharmaceuticals, Inc., San Diego |
Diaryl- und arylheteroarylharnstoffderivate als modulatoren des 5-ht2a-serotoninrezeptors, die sich zur prophylaxe und behandlung von damit im zusammenhang stehenden erkrankungen eignen
|
MXPA06001417A
(es)
|
2003-08-04 |
2006-05-15 |
Pfizer Prod Inc |
Composiciones farmaceuticas de adsorbatos de farmacos amorfos y materiales que forman microfases lipofilas.
|
MX2008000396A
(es)
*
|
2005-06-22 |
2009-02-23 |
Elan Pharma Int Ltd |
Formulaciones de megestrol en nanoparticula.
|
WO2007112272A2
(en)
|
2006-03-28 |
2007-10-04 |
Javelin Pharmaceuticals, Inc. |
Formulations of low dose diclofenac and beta-cyclodextrin
|
CN101410012A
(zh)
*
|
2006-03-28 |
2009-04-15 |
杰佛林制药公司 |
低剂量的非甾体抗炎药和β-环糊精的制剂
|
AU2016203251B2
(en)
*
|
2006-06-30 |
2017-11-16 |
Iceutica Pty Ltd |
Methods for the Preparation of Biologically Active Compounds in Nanoparticle Form
|
JP5508003B2
(ja)
*
|
2006-06-30 |
2014-05-28 |
アイスイティカ ピーティーワイ リミテッド |
ナノ粒子状の形態における生物学的に活性な化合物の調製のための方法
|
CL2007002689A1
(es)
|
2006-09-18 |
2008-04-18 |
Vitae Pharmaceuticals Inc |
Compuestos derivados de piperidin-1-carboxamida, inhibidores de la renina; compuestos intermediarios; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como hipertension, insuficiencia cardiaca, fibrosis cardiaca, entre otras.
|
TWI415845B
(zh)
|
2006-10-03 |
2013-11-21 |
Arena Pharm Inc |
用於治療與5-ht2a血清素受體相關聯病症之作為5-ht2a血清素受體之調節劑的吡唑衍生物
|
WO2009023253A2
(en)
|
2007-08-15 |
2009-02-19 |
Arena Pharmaceuticals Inc. |
IMIDAZO[L,2-α]PYRIDINE DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO
|
US8821924B2
(en)
*
|
2007-09-14 |
2014-09-02 |
Wockhardt Ltd. |
Rhein or diacerein compositions
|
US20100285114A1
(en)
*
|
2007-09-27 |
2010-11-11 |
Rahul Dabre |
Pharmaceutical compositions of rhein or diacerein
|
CA2709236A1
(en)
*
|
2007-09-27 |
2009-04-02 |
Wockhardt Research Centre |
Pharmaceutical compositions of rhein or diacerein
|
WO2009048940A2
(en)
*
|
2007-10-08 |
2009-04-16 |
Dr. Reddy's Laboratories Ltd. |
Diacerein pharmaceutical formulations
|
US8642062B2
(en)
|
2007-10-31 |
2014-02-04 |
Abbott Cardiovascular Systems Inc. |
Implantable device having a slow dissolving polymer
|
US20110021538A1
(en)
|
2008-04-02 |
2011-01-27 |
Arena Pharmaceuticals, Inc. |
Processes for the preparation of pyrazole derivatives useful as modulators of the 5-ht2a serotonin receptor
|
ES2666324T3
(es)
|
2008-10-28 |
2018-05-04 |
Arena Pharmaceuticals, Inc. |
Composiciones de un modulador del receptor de serotonina 5-HT2A útiles para el tratamiento de trastornos relacionados con el mismo
|
US8778401B2
(en)
*
|
2008-10-28 |
2014-07-15 |
Agency For Science, Technology And Research |
Mesoporous material excipients for poorly aqueous soluble ingredients
|
WO2010062321A1
(en)
|
2008-10-28 |
2010-06-03 |
Arena Pharmaceuticals, Inc. |
Processes useful for the preparation of 1-[3-(4-bromo-2-methyl-2h-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro-phenyl)-urea and crystalline forms related thereto
|
US7828996B1
(en)
|
2009-03-27 |
2010-11-09 |
Abbott Cardiovascular Systems Inc. |
Method for the manufacture of stable, nano-sized particles
|
BRPI1014275B8
(pt)
|
2009-04-24 |
2021-05-25 |
Iceutica Pty Ltd |
composição que compreende partículas de indometacina dispersas em pelo menos dois materiais de moagem parcialmente moídos
|
EP2442643A4
(en)
*
|
2009-06-17 |
2014-08-06 |
Isp Investments Inc |
PROCESS FOR THE PREPARATION OF STABLE, MICROENCAPSULATED AND SLOWLY RELEASED BIOCIDAL ACTIVE SUBSTANCES AND RELATED COMPOSITION
|
AR077692A1
(es)
|
2009-08-06 |
2011-09-14 |
Vitae Pharmaceuticals Inc |
Sales de 2-((r)-(3-clorofenil) ((r)-1-((s) -2-(metilamino)-3-((r)-tetrahidro-2h-piran-3-il) propilcarbamoil) piperidin -3-il) metoxi) etilcarbamato de metilo
|
JP5870775B2
(ja)
*
|
2011-05-11 |
2016-03-01 |
ライオン株式会社 |
錠剤及びその製造方法
|
US9150513B2
(en)
|
2011-07-22 |
2015-10-06 |
Chemocentryx, Inc. |
Polymorphic forms of the sodium salt of 4-tert-butyl-N-[4-chloro-2-(1-oxy-pyridine-4-carbonyl)-phenyl]-benzene sulfonamide
|
HUE032747T2
(en)
|
2011-07-22 |
2017-10-30 |
Chemocentryx Inc |
Crystalline form of the sodium salt of 4-tert-butyl-N- [4-chloro-2- (1-oxypyridine-4-carbonyl) phenyl] benzenesulfonamide
|
KR101378951B1
(ko)
*
|
2011-07-29 |
2014-03-31 |
재단법인 유타 인하 디디에스 및 신의료기술개발 공동연구소 |
생체이용률이 향상된 초산 메게스트롤 분말을 포함하는 경구투여용 제제 및 이의 제조방법
|
MY172885A
(en)
|
2011-09-01 |
2019-12-13 |
Glaxo Group Ltd |
Novel crystal form
|
WO2013032310A1
(ko)
*
|
2011-09-02 |
2013-03-07 |
재단법인 유타 인하 디디에스 및 신의료기술개발 공동연구소 |
메게스트롤 속붕해정 및 이의 제조 방법
|
US20140371318A1
(en)
*
|
2011-12-23 |
2014-12-18 |
Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi |
Orally-disintegrating formulations of flurbiprofen
|
US20150004229A1
(en)
*
|
2011-12-27 |
2015-01-01 |
Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi |
Combined pharmaceutical formulation containing diacerein
|
ITMI20120092A1
(it)
|
2012-01-26 |
2013-07-27 |
Micro Macinazione S A |
Compositi di inclusione farmaco-carrier preparati con processo di attivazione meccano-chimica mediante mulini a getto di fluido ad alta energia
|
KR102237799B1
(ko)
|
2012-11-14 |
2021-04-08 |
더블유.알. 그레이스 앤드 캄파니-콘. |
생물학적 활성 물질 및 비-정렬된 무기 산화물을 함유하는 조성물
|
US9526734B2
(en)
|
2014-06-09 |
2016-12-27 |
Iceutica Pty Ltd. |
Formulation of meloxicam
|
ES2869374T3
(es)
|
2014-06-25 |
2021-10-25 |
Glaxosmithkline Ip Dev Ltd |
Sales cristalinas de (S)-6-((1-acetilpiperidin-4-il)amino)-n-(3-(3,4-dihidroisoquinolin-2(1h)-il)-2-hidroxipropil)pirimidin-4-carboxamida
|
CN107148418A
(zh)
|
2014-09-08 |
2017-09-08 |
葛兰素史密斯克莱知识产权发展有限公司 |
2‑(4‑(4‑乙氧基‑6‑氧代‑1,6‑二氢吡啶‑3‑基)‑2‑氟苯基)‑n‑(5‑(1,1,1‑三氟‑2‑甲基丙‑2‑基)异噁唑‑3‑基)乙酰胺的晶型
|
JP2018516992A
(ja)
|
2015-06-12 |
2018-06-28 |
アクソファント サイエンシーズ ゲーエムベーハーAxovant Sciences Gmbh |
レム睡眠行動障害の予防および処置のために有用なジアリールおよびアリールヘテロアリール尿素誘導体
|
RU2018103338A
(ru)
|
2015-07-15 |
2019-08-15 |
Аксовант Сайенсиз Гмбх |
Производные диарил- и арилгетероарилмочевины для профилактики и лечения галлюцинаций, ассоциированных с нейродегенеративным заболеванием
|